Boothbay Fund Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-810
| Closed | -$290K | – | 1711 |
|
|
2024
Q3 | $290K | Buy |
+810
| New | +$290K | 0.01% | 1087 |
|
|
2022
Q3 | – | Sell |
-5,104
| Closed | -$1.2M | – | 2303 |
|
|
2022
Q2 | $1.2M | Buy |
+5,104
| New | +$1.2M | 0.03% | 655 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2198 |
|
|
2021
Q4 | – | Sell |
-6,549
| Closed | -$1.21M | – | 2019 |
|
|
2021
Q3 | $1.21M | Sell |
6,549
-1,240
| -16% | -$229K | 0.03% | 535 |
|
|
2021
Q2 | $1.4M | Sell |
7,789
-1,658
| -18% | -$297K | 0.04% | 473 |
|
|
2021
Q1 | $1.58M | Buy |
9,447
+7,638
| +422% | +$1.28M | 0.06% | 320 |
|
|
2020
Q4 | $275K | Buy |
+1,809
| New | +$275K | 0.01% | 832 |
|
|
2017
Q2 | – | Sell |
-2,080
| Closed | -$282K | – | 769 |
|
|
2017
Q1 | $282K | Buy |
+2,080
| New | +$282K | 0.05% | 376 |
|